Abstract
A compound that targets the Wnt signaling pathway in cancer moves into therapeutic trials, 30 years after Wnt was discovered.
| Original language | English |
|---|---|
| Pages (from-to) | 922-923 |
| Number of pages | 2 |
| Journal | Science |
| Volume | 337 |
| Issue number | 6097 |
| DOIs | |
| Publication status | Published - 24 Aug 2012 |
| Externally published | Yes |